This economic evaluation concludes that Argus II Retinal Prosthesis System is a cost-effective device to treat RP patients. Argus II is the only licensed device available to restore some sight in ...

Argus II is a novel healthcare technology that restores vision in RP patients. Improvements in visual acuity are expected to lead to improvements in patient self-confidence, decreasing their ...

The Argus II Retinal Prosthesis System isn’t quite that advanced. But for the vision-impaired, the “bionic retina” is a huge leap forward. The device, which was created by the California ...

The company said its Argus 2s Retinal Prosthesis System was approved initially for use in combination with previously implanted Argus II systems to treat retinitis pigmentosa. Second Sight shares ...

On Dec. 5, the company announced it had entered the market in Iran by implanting two patients with its Argus II Retinal Prosthesis System. This is part of the company's strategy to target leading ...

Others can see with the aid of a visual prosthesis. The Argus II, nicknamed the "bionic eye," holds immense promise for people with a particular kind of blindness, retinitis pigmentosa ...

Independent Online, popularly known as IOL, is one of South Africa’s leading news and information websites bringing millions of readers breaking news and updates on Politics, Current Affairs ...

The Times Argus welcomes letters to the editor. We endeavor to publish all letters, but they should be short (no more than 300 words) and to the point.To submit your letter to the editor, please fill ...

2-Year U.S. Treasury Note Continuous Contract $102.957-0.051-0.05% 5-Year U.S. Treasury Note Continuous Contract $107.250-0.125-0.12% 10-Year U.S. Treasury Note Continuous Contract $110.516-0.188 ...